1. Home
  2. Southern Africa
  3. Mozambique
  • News

UNICEF dismisses free HIV/AIDS drug claim

The UN Children's Fund (UNICEF) on Friday dismissed reports that a free supply of antiretrovirals would be made available to pregnant HIV-positive women in Mozambique soon. "The free supply will only become available once the government has submitted its application to the German pharmaceutical company [Boehringer-Ingelheim ]," UNICEF communication officer Michael Klaus told the UN news service Plusnews. In 2000 German multinational, Boehringer-Ingelheim, made the offer of a free five-year supply of nevirapine to developing countries for use in the prevention of mother-to-child transmission of HIV/AIDS. Klaus said UNICEF and the government are still in the process of preparing the documentation that will allow the country its share of the offer. The Mozambique news agency AIM on Friday reported the programme will start in hospitals in the central cities of Beira and Chimoio this year and will then expand to a hospital in Gaza province.

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join